Abstract
Cerebral blood flow, cerebral oxygen metabolic rate and cerebral glucose metabolic rate were measured with positron emission tomography (PET) in four patients with progressive supranuclear palsy (PSP). Decreased blood flow and hypometabolism of oxygen and glucose were found in both subcortical and cortical regions, particularly in the striatum including the head of the caudate nucleus and the frontal cortex. The coupling between blood flow and metabolism was preserved even in the regions which showed decreased blood flow and hypometabolism. These findings indicated the hypofunction, as revealed by decreased blood flow and hypometabolism on PET, both in the striatum and the frontal cortex, and which may underlie the pathophysiological mechanism of motor and mental disturbance in PSP.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Steele JC: Progressive supranuclear palsy.Brain 95: 693–704, 1972
Steele JC, Richardson JC, Olszewski T: Progressive supranuclear palsy.Arch Neurol 10: 333–359, 1964
Albert ML, Feldman RG, Willis AL: The ‘subcortical dementia’ of supranuclear palsy.J Neurol Neurosurg Pyschiatry 37: 121–130, 1974
Cummings JL, Benson DF: Subcortical dementia.Arch Neurol 41: 874–879, 1984
Benson DF, Kuhl DE, Hawkins RA, et al: The fluorodeoxyglucose F-18 scan in Alzheimer’s disease and multi-infarct dementia.Arch Neurol 40: 711–714, 1983
de Leon MJ, Ferris SH, George AE, et al: Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer’s disease.J Cereb Blood Flow Metab 3: 391–394, 1983
Foster NL, Chase TN, Fedio P, et al: Alzheimer’s disease: focal cortical changes shown by positron emission tomography.Neurology 33: 961–965, 1983
Frackowiak RSJ, Pozzilli C, Legg NJ, et al: Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.Brain 104: 753–778, 1981
Friedland RP, Budinger TF, Ganz E, et al: Regional cerebral metabolic alterations in dementia of Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.J Comput Assist Tomogr 7: 590–598, 1983
McGeer PL, Kamo H, Harrop R, et al: Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer’s disease.Neurology 36: 1569–1574, 1986
D’Antona R, Baron JC, Samson Y, et al: Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supra nuclear palsy.Brain 108: 785–799, 1985
Leenders KL, Frackowiak RSJ, Lees AJ: Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography.Brain 111: 615–630, 1988
Kanno I, Miura S, Yamamoto S, et al: Design and evaluation of the positron emission tomograph: HEADTOME III.Comput Assist Tomogr 9: 931–939, 1985
Frackowiak RSJ, Lenzi GL, Jones T, et al: Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using15O and positron emission tomography: Theory, procedure and normal values.J Comput Assist Tomogr 4: 723–736, 1980
Lammertsma AA, Jones T: Correlation for the presence of intravascular oxygen-15 in the steadystate technique for measuring regional oxygen extraction ratio in the brain: 1. Description of the method.J Cereb Blood Flow Metab 3: 416–424, 1983
Lammertsma AA, Wise RJS, Heather JD, et al: Correlation for the presence of intravascular oxygen- 15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 2. Results in normal subjects and brain tumour and stroke patients.J Cereb Blood Flow Metab 3: 425–431, 1983
Sokoloff L, Reivich M, Kennedy C, et al: The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization. theory, procedure, and normal values in the conscious and anesthetized albino rat.J Neurochem 28: 897–916, 1977
Hutchins GD, Holden JE, Koeppe RA, et al: Alternative approach to single-scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia.J Cereb Blood Flow Metab 4: 35–40, 1984
Ishino H, Ikeda H, Otsuki S: Contribution to clinical pathology of progressive supranuclear palsy (subcortical argyrophilic dystrophy) on the distribution of neuro-fibrillary tangles in the basal ganglia and brainstem and its clinical significance.J Neurol Sciences 24: 471–481, 1975
Blumenthal H, Miller C: Motor nuclear involvement in progressive supranuclear palsy.Arch Neurol 20: 362–367, 1969
David NJ, Mackay EA, Smith JL: Further observations in progressive supranuclear palsy.Neurology 18: 349–356, 1968
Weinmann RL: Heterogenuous system degeneration of the central nervous system associated with peripheral neuropathy.Neurology 17: 597–603, 1967
Ishino H, Otsuki S: Frequency of Alzheimer’s neurofibrillary tangles in the cerebral cortex in progressive supranuclear palsy (subcortical argyrophilic dystrophy).J Neurol Sciences 28: 309–316, 1976
Rokoloff L: Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose.J Cereb Blood Flow Metab 1: 7–36, 1981
Kamo H, McGeer PL, Harrop R, et al: Positron emission tomography and histopathology in Pick’s disease.Neurology 37: 439–445, 1987
Ichimiya A, Yamada S, Suetsugu M, et al: Cerebral metabolic changes observed in cortical dementia by positron emission tomography using F-18-FDG.Jpn J Nucl Med [Abstract], 1988 (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Otsuka, M., Ichiya, Y., Kuwabara, Y. et al. Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy. Ann Nucl Med 3, 111–118 (1989). https://doi.org/10.1007/BF03178296
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03178296